These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17694494)

  • 1. Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes.
    Jalilian AR; Rowshanfarzad P; Kamrani YY; Shafaii K; Mirzaii M
    Nucl Med Rev Cent East Eur; 2007; 10(1):6-11. PubMed ID: 17694494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and formulation of [
    Green MA; Mathias CJ
    Appl Radiat Isot; 2022 Apr; 182():110119. PubMed ID: 35093818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention of the radiotracers 64Cu-ATSM and 64Cu-PTSM in human and murine tumors is influenced by MDR1 protein expression.
    Liu J; Hajibeigi A; Ren G; Lin M; Siyambalapitiyage W; Liu Z; Simpson E; Parkey RW; Sun X; Oz OK
    J Nucl Med; 2009 Aug; 50(8):1332-9. PubMed ID: 19617332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
    Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
    Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
    Lewis JS; McCarthy DW; McCarthy TJ; Fujibayashi Y; Welch MJ
    J Nucl Med; 1999 Jan; 40(1):177-83. PubMed ID: 9935074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
    Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM
    J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical studies of [61Cu]ATSM as a PET radiopharmaceutical for fibrosarcoma imaging.
    Jalilian AR; Rostampour N; Rowshanfarzad P; Shafaii K; Kamali-Dehghan M; Akhlaghi M
    Acta Pharm; 2009 Mar; 59(1):45-55. PubMed ID: 19304557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM.
    Mathias CJ; Welch MJ; Raichle ME; Mintun MA; Lich LL; McGuire AH; Zinn KR; John EK; Green MA
    J Nucl Med; 1990 Mar; 31(3):351-9. PubMed ID: 2308007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
    Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
    J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.
    Green MA; Klippenstein DL; Tennison JR
    J Nucl Med; 1988 Sep; 29(9):1549-57. PubMed ID: 3261785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of copper radiopharmaceuticals with mixed bis(thiosemicarbazone) ligands.
    Ackerman LJ; West DX; Mathias CJ; Green MA
    Nucl Med Biol; 1999 Jul; 26(5):551-4. PubMed ID: 10473194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of a 62Zn/62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM.
    Haynes NG; Lacy JL; Nayak N; Martin CS; Dai D; Mathias CJ; Green MA
    J Nucl Med; 2000 Feb; 41(2):309-14. PubMed ID: 10688116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin.
    Mathias CJ; Bergmann SR; Green MA
    J Nucl Med; 1995 Aug; 36(8):1451-5. PubMed ID: 7629593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion.
    Green MA; Mathias CJ; Welch MJ; McGuire AH; Perry D; Fernandez-Rubio F; Perlmutter JS; Raichle ME; Bergmann SR
    J Nucl Med; 1990 Dec; 31(12):1989-96. PubMed ID: 2266398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cell-labeling methods with ¹²⁴I-FIAU and ⁶⁴Cu-PTSM for cell tracking using chronic myelogenous leukemia cells expressing HSV1-tk and firefly luciferase.
    Park JJ; Lee TS; Son JJ; Chun KS; Song IH; Park YS; Kim KI; Lee YJ; Kang JH
    Cancer Biother Radiopharm; 2012 Dec; 27(10):719-28. PubMed ID: 23009582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species dependence of [64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins.
    Basken NE; Mathias CJ; Lipka AE; Green MA
    Nucl Med Biol; 2008 Apr; 35(3):281-6. PubMed ID: 18355683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo tracking of Th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue.
    Griessinger CM; Kehlbach R; Bukala D; Wiehr S; Bantleon R; Cay F; Schmid A; Braumüller H; Fehrenbacher B; Schaller M; Eichner M; Sutcliffe JL; Ehrlichmann W; Eibl O; Reischl G; Cherry SR; Röcken M; Pichler BJ; Kneilling M
    J Nucl Med; 2014 Feb; 55(2):301-7. PubMed ID: 24434289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential copper radiopharmaceutical for imaging the heart and brain: copper-labeled pyruvaldehyde bis(N4-methylthiosemicarbazone).
    Green MA
    Int J Rad Appl Instrum B; 1987; 14(1):59-61. PubMed ID: 3583756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model.
    Young H; Carnochan P; Zweit J; Babich J; Cherry S; Ott R
    Eur J Nucl Med; 1994 Apr; 21(4):336-41. PubMed ID: 8005157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue blood flow estimation with copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) and PET.
    Young H; Carnochan P; Zweit J; Babich J; Cherry S; Ott R
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):89-91. PubMed ID: 7632775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.